Top compounds associated with response to TMEM266


Feature Type Standardized
Nominal ANOVA
mRNA Topotecan CCLE pan-cancer AAC -0.00028 1
mRNA purmorphamine CTRPv2 pan-cancer AAC -0.0002 1
mRNA Methotrexate CTRPv2 pan-cancer AAC -8.3e-05 1
mRNA Sunitinib GDSC1000 pan-cancer AAC 9.4e-05 1
Download CSV